Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 2 interventional trial registration with no reported results; the study is active but not yet recruiting and outcome data are not posted in the registry.
Phase 1 dose-escalation trial with 29 enrolled participants testing safety and maximum tolerated dose; no efficacy results reported in this registry record.
This is a Phase 1/2 trial registration with no posted results; it describes a planned early-phase study of a novel combination in a difficult-to-treat cancer.
This is a suspended Phase 2 trial registration with no results reported; it describes a planned intervention but carries no outcome data to evaluate efficacy or safety.
This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and enrollment only, with no outcome data available for assessment.
This is a Phase 2 trial registration with no results posted; it describes a planned interventional study testing TRC102 added to chemoradiotherapy in stage III NSCLC, designed to assess feasibility and signal before larger trials.
This is a Phase 2 trial still recruiting with no results posted; it represents early-phase investigation of lutetium Lu 177 dotatate versus everolimus in bronchial neuroendocrine tumors.
This is a recruiting feasibility study with no posted results; it describes planned enrollment and outcome measures only, precluding any assessment of efficacy or clinical impact.